Cas no for 129938-20-1,Dapoxetine hydrochloride ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 129938-20-1

129938-20-1

[CAS Name] Dapoxetine hydrochloride

[Formula] C21H24ClNO

Search Products Post Sourcing Request

Basica Info

[CAS Name]Dapoxetine hydrochloride
[Alias]DAPOXETINE HCL; Rimonabant 75000; LY-21044; ((S)-(+)-N,N-Dimethyl-1-phenyl-3-(1-naphthalenyloxy)propanamine hydrochloride); (S-(+)-N,N-dimethyl-a-[2-(naphthalenyloxy)ethyl] benzenemethanamine hydrochloride; (1S)-N,N-Dimethyl-3-naphthalen-1-yloxy-1-phenyl-propan-1-amine hydrochloride; (S)-n,n-dimethyl-3-(naphthalene-1-yloxy)-1-phenylpropan-1-amine hydrochloride; (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride; (S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanamine hydrochloride; N,N-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride (1:1); DL-Dapoxteine HCL
[Number]129938-20-1
[EINECS]
[Formula]C21H24ClNO
[Molecular weight]341.8744

[Melting point]175-1790C
[Boiling point]480.5°C at 760 mmHg
[Density]1.27E-09mmHg at 25°C
[Flash point]244.4°C

129938-20-1 Suppliers

Company

Main Products

Kinhoo Pharmaceutical Co., Ltd.

pharmaceutical grade

Send Inquiry

Shandong Loncom Pharmaceutical Co.Ltd.

Product Name: Dapoxetine hydrochloride

Chemical Name:

(S-(+)-N,N-Dimethyl-a-[2-(naphthalenyloxy)ethyl]benzenemethanamine hydrochloride

CAS NO.: 129938-20-1

Molecular Formula: C21H23NO.HCl

Molecular Weight: 341.88

Appearance: White to off-white powder

Standard: 99%

Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005, the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions.

Send Inquiry